Bausch + Lomb

Bausch + Lomb
Global eye health company offering contact lenses, lens care, supplements, and prescription pharmaceuticals.
About
What does Bausch + Lomb do?
Bausch + Lomb is a global leader in eye health, providing a comprehensive range of products designed to improve and preserve vision. Their offerings include contact lenses, lens care solutions, over-the-counter eye care supplements, and prescription pharmaceuticals for various eye conditions, serving both consumers and eye care professionals.
Where is Bausch + Lomb headquartered?
Bausch + Lomb is headquartered in Vaughan, Canada.
When was Bausch + Lomb founded?
Bausch + Lomb was founded in 1933.
What industry does Bausch + Lomb operate in?
Bausch + Lomb operates in MedTech, HealthTech, Biotech, Drug Discovery, Contact Lenses, Ophthalmology.
Medbytes provides doctors with a personalized platform for high-impact medical research and news in their specialty.
Provider-supervised peptide therapy, NAD+ support, and cognitive enhancement for cellular renewal, recovery, and healthy aging.
Your health consultation for a pain-free life, offering pain management and therapy solutions.
An AI-powered platform for cancer patients and survivors in Asia to navigate care and understand their diagnosis.
AI-powered personalized sleep coaching and actionable insights for improving sleep quality.
SomaIQ drafts the interpretation and patient explanation for your review, reducing a 90-minute task to five.
AI-powered digital health platform offering personalized nutrition and wellness plans based on individual metabolism.
Akylmed is developing an AI-powered platform to streamline medical documentation and administrative tasks for healthcare providers.
An entrant is a company tagged MedTech whose domain was first registered in the window, counted from registry records in the StartupHub directory. 1 of them registered in the last 30 days. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.